We are a healthcare company that focuses on women’s health and providing unique solutions to diagnostic and therapeutic challenges. AIMA is developing what will be the first, non-invasive diagnostic tool for endometriosis on the market. If you are experiencing chronic pelvic pain/period pain or are having trouble getting pregnant you may have endometriosis.

We will be participating in the BioCreate program and have been awarded $150,000 to further develop our team and commercialization steps for our diagnostic tool for endometriosis.

Additionally, we have been recognized for the I.d.e.a Fund and have been awarded $30,000 in SEED funding.

AIMA Laboratories mission is to develop and distribute new products to fill current gaps in women’s health. The flagship product will provide clarity and offer peace-of-mind to people experiencing chronic pelvic pain, menstrual pain, or infertility caused by endometriosis.

AIMA Laboratories vision is to be an international player in the women’s health marketplace. The first step is to be the North American market leader for the diagnosis of endometriosis.